Bharath Pannuri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bharath Pannuri has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- D. Ramachandran
University College of Sciences, Acharya Nagarjuna University
3 shared publications - Manukonda Gowrisankar
J.K.C. College, ANU
2 shared publications - N.V.N.B. Srinivasa Rao
University College of Sciences, Acharya Nagarjuna University
2 shared publications - Nanduri Gayatri Devi
Ch.S.D.St.Theresa’s College for Women(A)
2 shared publications - Ramanjaneyulu Epperla
University College of Sciences, Acharya Nagarjuna University
2 shared publications - Angeline Jyothirmayee Chikkala
Department of Chemistry, Ch. S. D. St. Theresa’s College for Women (A)
1 shared publication
Latest Publications
- 8 September 2026
- Published by Wiley in Separation Science Plus
- Vol. 9 (9)
Isolation and Structural Elucidation of Oxidative Degradation Products of Bosutinib by Preparative HPLC, LC–MS, and NMR Spectroscopy
Bosutinib (BST), a 4‐anilino‐3‐quinolinecarbonitrile derivative, is a tyrosine kinase inhibitor approved for the treatment of chronic myelogenous leukemia. To assess the chemical stability of BST and elucidate its degradation pathways, forced degradation studies were conducted in accordance with International Council for Harmonisation quality guidelines Q1A(R2). Chromatographic analysis under oxidative stress conditions revealed the formation of two major degradation products (DP's), eluting at relative retention times of approximately 1.09 and 1.14, with respective abundances of 15% and 76%. These were isolated using preparative high‐performance liquid chromatography and structurally characterized using liquid chromatography–mass spectrometry and nuclear magnetic resonance spectroscopy. LC–mass spectrometry (MS) analysis indicated mass increases of +16 and +32 Da, consistent with mono‐ and di ‐oxidation, respectively. Nuclear magnetic resonance (NMR) data ( 1 H, 13 C, and 2D experiments) localized the oxidative modifications to the piperazinyl‐propoxy side chain and the aromatic methoxy groups. The identification and structural elucidation of these oxidative DP's are critical for understanding the degradation pathways of BST. This work underscores the importance of comprehensive impurity profiling not only for regulatory compliance and formulation development but also for ensuring drug product safety, particularly in oncology therapies where patient risk tolerance is low.
- 8 September 2026
- Published by Wiley in Separation Science Plus
- Vol. 9 (9)
Isolation and Structural Elucidation of Oxidative Degradation Products of Bosutinib by Preparative HPLC, LC–MS, and NMR Spectroscopy
Bosutinib (BST), a 4‐anilino‐3‐quinolinecarbonitrile derivative, is a tyrosine kinase inhibitor approved for the treatment of chronic myelogenous leukemia. To assess the chemical stability of BST and elucidate its degradation pathways, forced degradation studies were conducted in accordance with International Council for Harmonisation quality guidelines Q1A(R2). Chromatographic analysis under oxidative stress conditions revealed the formation of two major degradation products (DP's), eluting at relative retention times of approximately 1.09 and 1.14, with respective abundances of 15% and 76%. These were isolated using preparative high‐performance liquid chromatography and structurally characterized using liquid chromatography–mass spectrometry and nuclear magnetic resonance spectroscopy. LC–mass spectrometry (MS) analysis indicated mass increases of +16 and +32 Da, consistent with mono‐ and di ‐oxidation, respectively. Nuclear magnetic resonance (NMR) data ( 1 H, 13 C, and 2D experiments) localized the oxidative modifications to the piperazinyl‐propoxy side chain and the aromatic methoxy groups. The identification and structural elucidation of these oxidative DP's are critical for understanding the degradation pathways of BST. This work underscores the importance of comprehensive impurity profiling not only for regulatory compliance and formulation development but also for ensuring drug product safety, particularly in oncology therapies where patient risk tolerance is low.
- 26 February 2026
- Published by Taylor & Francis in Physics and Chemistry of Liquids
- Vol. 64 (2) , 376-388
Thermodynamic and Transport Properties of Binary Mixtures of 2-Nitroanisole with Isomeric Dimethylanilines: Experimental and Correlative Study
1. The study of the thermodynamic and transport properties of liquid mixtures plays a vital role in understanding molecular interactions, solution behaviour, and the design of separation processes....
- 26 February 2026
- Published by Taylor & Francis in Physics and Chemistry of Liquids
- Vol. 64 (2) , 376-388
Thermodynamic and Transport Properties of Binary Mixtures of 2-Nitroanisole with Isomeric Dimethylanilines: Experimental and Correlative Study
1. The study of the thermodynamic and transport properties of liquid mixtures plays a vital role in understanding molecular interactions, solution behaviour, and the design of separation processes....
- 20 February 2026
- Published by Taylor & Francis in Physics and Chemistry of Liquids
- Vol. 64 (2) , 357-369
Excess thermodynamic and transport properties of 2-nitroanisole + alkanolamine binary mixtures: experimental and Jouyban–Acree Model Analysis
- 20 February 2026
- Published by Taylor & Francis in Physics and Chemistry of Liquids
- Vol. 64 (2) , 357-369
Excess thermodynamic and transport properties of 2-nitroanisole + alkanolamine binary mixtures: experimental and Jouyban–Acree Model Analysis
- 19 February 2026
- Published by Taylor & Francis in Synthetic Communications
- Vol. 56 (5) , 382-408
Green synthesis, ADME and docking studies, and in vitro assessment of chromone-based α -aminophosphonates as dual inhibitors of α -amylase and α -glucosidase
- 19 February 2026
- Published by Taylor & Francis in Synthetic Communications
- Vol. 56 (5) , 382-408
Green synthesis, ADME and docking studies, and in vitro assessment of chromone-based α -aminophosphonates as dual inhibitors of α -amylase and α -glucosidase